MOHAMMED ARRASSI: Open Payments
NPI 1669130019 · BROWNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 8 payments from 6 companies in 2025. Trend: 2023 $57 · 2024 $0 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: Ozempic, AIRSUPRA, ELIQUIS, Kerendia, QULIPTA.
Industry payments across PA — which companies pay providers there.
